Evidence map›Paper›PMID 27006257›Full record

ArticleThe International journal on drug policy2016

Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam.

Don C Des Jarlais, Duong Thi Huong, Khuat Thi Hai Oanh, Minh Khuê Pham, Hoang Thi Giang, Nham Thi Tuyet Thanh, Kamyar Arasteh, Jonathan Feelemyer, Theodore Hammett, Marianne Peries and 7 more

3 registry-linked trialsAbstract read
In one paragraph

Article in The International journal on drug policy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02573948 completednot on this map

Feasibility of an Interventional Project to Reduce HIV Incidence Among People Who Inject Drugs in Haiphong, Viet Nam

TypeobservationalSponsorANRS, Emerging Infectious DiseasesRan2014 to 2016Enrolled603ConditionsHIV, Hepatitis Virus, Substance AbuseArmsno intervention is assessed
NCT03526939 completednot on this map

DRIVE (DRug Use and Infections in ViEtnam) Project : Ending the HIV Epidemic Among Persons Who Inject Drugs in Hai Phong, Viet Nam

TypeobservationalSponsorNew York UniversityRan2016 to 2020Enrolled5,546ConditionsHIV, Hepatitis C, Mental Health
NCT04706624 nacompletednot on this mapstarted 2021, after this paper: background citation

Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics

TypeinterventionalSponsorHanoi Medical UniversityRan2021 to 2025Enrolled667ConditionsMethamphetamine Abuse, Opioid-use Disorder, HIV SeropositivityArmsContingency management (12 weeks), Contingency management (6 weeks), SMS reminders, Matrix only, Matrix + Contingency management
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Don C Des JarlaisIcahn School of Medicine at Mount Sinai, New York City, USA. Electronic address: ddesjarlais@chpnet.org.
Duong Thi HuongHai Phong University of Medicine and Pharmacy, Hai Phong, Viet Nam.
Khuat Thi Hai OanhSupporting Community Development Initiatives, Hanoi, Viet Nam.
Minh Khuê PhamHai Phong University of Medicine and Pharmacy, Hai Phong, Viet Nam.
Hoang Thi GiangHai Phong University of Medicine and Pharmacy, Hai Phong, Viet Nam.
Nham Thi Tuyet ThanhSupporting Community Development Initiatives, Hanoi, Viet Nam.
Kamyar ArastehIcahn School of Medicine at Mount Sinai, New York City, USA.
Jonathan FeelemyerIcahn School of Medicine at Mount Sinai, New York City, USA.
Theodore HammettAbt Associates, Cambridge, MA, USA.
Marianne PeriesInserm U1058, Etablissement Français du Sang, University of Montpellier, France.
Laurent MichelPierre Nicole Center, Red Cross, Paris, France.
Vinh Vu HaiInfectious Diseases Department, Viet Tiep Hospital, Hai Phong, Viet Nam.
Marie Jauffret RoustideInserm, Paris, France.
Jean-Pierre MolesInserm U1058, Etablissement Français du Sang, University of Montpellier, France.
Didier LaureillardInserm U1058, Etablissement Français du Sang, University of Montpellier, France; Infectious Diseases Department, Caremeau University Hospital, Nîmes, France.
Nicolas NagotInserm U1058, Etablissement Français du Sang, University of Montpellier, France.
DRIVE Study Team

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet NamR01DA041978 · NIDA · NEW YORK UNIVERSITY · PI DES JARLAIS, DON C · 2016 to 2020
$4.9M
NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA041978
6 · The paper itself

Abstract

backgroundTo examine the prospects for "ending the HIV epidemic" among persons who inject drugs (PWID) in Haiphong, Vietnam. Reaching an incidence of <0.5/100 person-years at risk (PY) was used as an operational definition for "ending the epidemic."

methodsA respondent driven sampling study of 603 PWID was conducted from September to October 2014. Current heroin use (verified with urine testing and marks of injection) was an eligibility requirement. A structured questionnaire was administered by trained interviewers to obtain demographic, drug use, and risk behavior data; HIV counseling and testing and HCV testing was also conducted. Two methods (by assuming all new injectors were HIV negative at first injection and by slope of prevalence by years injecting) were used for estimating HIV among persons injecting for <5 years ("new injectors"). Comparisons were made to the HIV epidemic among PWID in New York City and modeling of the HIV epidemic in Can Tho province.

resultsHIV prevalence was 25% in 2014, down from 68% in 2006 and 48% in 2009; overall HCV prevalence in the study was 67%. Among HIV seropositive PWID, 33% reported receiving antiretroviral treatment. The great majority (83%) of subjects reported pharmacies as their primary source of needles and syringes and self-reported receptive and distributive syringe sharing were quite low (<6%). Estimating HIV incidence among non-MSM male new injectors with the assumption that all were HIV negative at first injection gave a rate of 1.2/100 person-years (95% CI -0.24, 3.4). Estimating HIV incidence by the slope of prevalence by years injecting gave a rate of 0.8/100 person-years at risk (95% CI -0.9, 2.5).

conclusionsThe current HIV epidemic among PWID in Haiphong is in a declining phase, but estimated incidence among non-MSM new injectors is approximately 1/100 person-years and there is a substantial gap in provision of ART for HIV seropositives. Scaling up interventions, particularly HIV counseling and testing and antiretroviral treatment for all seropositive PWID, should accelerate the decline. Ending the epidemic is an attainable public health goal.

Indexed as

AdultAnti-HIV AgentsCounselingEpidemicsFemaleHeroin DependenceHIV InfectionsHIV SeropositivityHumansIncidenceMaleMiddle AgedNeedle SharingNew York CityPrevalenceRisk-TakingAnti-HIV AgentsHIVMen who have sex with men (MSM)Persons who inject drugs (PWID)Respondent driven sampling (RDS)Sex workersVietnam

Identifiers

PMID27006257
PMCPMC4899107

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.